Shree Pushkar Chemicals: ₹29.99 Crore Warrant Funds Confirmed for Subsidiary CAPEX

Shree Pushkar Chemicals & Fertilisers Ltd. has provided an update on its preferential issue of warrants. The company confirmed no deviation in how the raised funds are being utilized. The total issue size is ₹29.99 crore. As of March 31, 2026, ₹7.50 crore had been received.

These funds are designated for capital expenditure on complex fertilisers and expansion projects at its subsidiary, Madhya Bharat Phosphate Private Limited. The remaining 75% of the funds are anticipated as warrant holders convert their holdings within the 18-month period following the warrants' allotment on December 27, 2025.

Why This Update Matters

This confirmation offers investors key clarity on how the capital raised is being used. It assures stakeholders that funds are directed toward stated goals, enhancing transparency. The update also signals the company's commitment to growing its fertiliser segment through strategic investments in its subsidiary, aiming to increase production capacity.

Company Background

Shree Pushkar Chemicals & Fertilisers Ltd. is a diversified Indian manufacturer of chemicals, dyes, intermediates, and fertilisers, operating multiple production facilities. Its subsidiary, Madhya Bharat Phosphate Private Limited, plays a key role in the company's expansion plans for the complex fertiliser market.

Key Risks to Monitor

A key risk is the pending amalgamation petition at the National Company Law Tribunal (NCLT) for Madhya Bharat Phosphate Private Limited, which is seeking to merge with Kisan Phosphates Private Limited. The NCLT's decision could affect how and when the funds are used. Furthermore, Shree Pushkar's ability to receive the full ₹29.99 crore depends on warrant holders exercising their conversion rights within the 18-month period.

What to Watch Next

Investors will be monitoring the NCLT's decision on the amalgamation petition for Madhya Bharat Phosphate Private Limited. Tracking warrant holder conversions and the subsequent inflow of funds remains critical. Updates on the subsidiary's capital expenditure project will also provide insights into future growth.